Juan Vilaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juan Vilaro has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Juan M. Aranda
University of Florida, Gainesville, FL
3 shared publications- Mohammad Al-Ani
Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, FL, United States
3 shared publications - Mustafa M. Ahmed
Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA
3 shared publications - Alex M. Parker
Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida
2 shared publications - Eric I. Jeng
Division of Cardiovascular Surgery, Department of Surgery, University of Florida College of Medicine, Gainesville, USA
2 shared publications - Steve Antoine
Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
2 shared publications
Latest Publications
- Open Access
- 23 December 2025
- Published by Elsevier in American Heart Journal Plus: Cardiology Research and Practice
- Vol. 62, 100704
Magnetocardiography for noninvasive surveillance of rejection and cardiac allograft vasculopathy in heart transplant recipients
- 23 December 2025
- Published by Elsevier in American Heart Journal Plus: Cardiology Research and Practice
- Vol. 62, 100704
Open AccessMagnetocardiography for noninvasive surveillance of rejection and cardiac allograft vasculopathy in heart transplant recipients
- Open Access
- 18 February 2024
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 29 (4) , 149-152
A case of cardiogenic shock due to ventricular dyssynchrony resolved by atrial pacing
- 18 February 2024
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 29 (4) , 149-152
Open AccessA case of cardiogenic shock due to ventricular dyssynchrony resolved by atrial pacing
- Open Access
- 1 January 2023
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 8 (1) , 20230058
Heart Failure with Preserved Ejection Fraction: Important Things to Know About the Stiff Heart
- 1 January 2023
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 8 (1) , 20230058
Open AccessHeart Failure with Preserved Ejection Fraction: Important Things to Know About the Stiff Heart
- 28 April 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (5) , S75
Recovery Of Allograft Right Ventricular Diastolic Dysfunction Post Heart Transplantation
- 28 April 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (5) , S75
Recovery Of Allograft Right Ventricular Diastolic Dysfunction Post Heart Transplantation
- 28 April 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (5) , S46
Outcome Of Patients With Systolic Heart Failure Undergoing Cardiac Sympathetic Denervation For Ventricular Arrhythmia
- 28 April 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 28 (5) , S46
Outcome Of Patients With Systolic Heart Failure Undergoing Cardiac Sympathetic Denervation For Ventricular Arrhythmia
- Open Access
- 26 January 2021
- Published by Springer Nature in Cureus
- Vol. 13 (1)
Cardiac Amyloid for the Internist
Cardiac amyloid is an uncommon cause of diastolic dysfunction the recognition of which requires the internist to have clinical suspicion to guide diagnosis and treatment. Cardiac amyloid is an infiltrative cardiomyopathy with significant morbidity and mortality. Appropriate diagnosis is important because management of cardiac amyloid differs from typical heart failure with preserved ejection fraction. An astute internist must be able to recognize common findings of cardiac amyloidosis. Here we present a case of a patient presenting with diastolic heart failure and the steps leading towards diagnosis and subsequent treatment.
- 26 January 2021
- Published by Springer Nature in Cureus
- Vol. 13 (1)
Open AccessCardiac Amyloid for the Internist
Cardiac amyloid is an uncommon cause of diastolic dysfunction the recognition of which requires the internist to have clinical suspicion to guide diagnosis and treatment. Cardiac amyloid is an infiltrative cardiomyopathy with significant morbidity and mortality. Appropriate diagnosis is important because management of cardiac amyloid differs from typical heart failure with preserved ejection fraction. An astute internist must be able to recognize common findings of cardiac amyloidosis. Here we present a case of a patient presenting with diastolic heart failure and the steps leading towards diagnosis and subsequent treatment.
- Open Access
- 8 June 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9) , 1347-1350
Severe COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction
- 8 June 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9) , 1347-1350
Open AccessSevere COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction
- Open Access
- 1 January 2019
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 3 (3) , 291-296
Stable Ischemic Heart Disease in the Older Adult
Demographic trends worldwide show a progressively aging population and an increase in the overall medical complexity of elderly patients with cardiovascular disease. Elderly patients, especially those aged 75 or older, are relatively underrepresented in many of the clinical trials that helped create major society guidelines for evaluation and management of ischemic heart disease. Consequently, risk benefit ratios of a guideline-based approach in these patients are not well defined, especially with regards to pharmacotherapies and percutaneous coronary interventions. In this article we offer a practical approach to defining the elderly population, and provide an evidenced based review of the diagnostic and therapeutic implications of advanced age in the evaluation and management of ischemic heart disease.
- 1 January 2019
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 3 (3) , 291-296
Open AccessStable Ischemic Heart Disease in the Older Adult
Demographic trends worldwide show a progressively aging population and an increase in the overall medical complexity of elderly patients with cardiovascular disease. Elderly patients, especially those aged 75 or older, are relatively underrepresented in many of the clinical trials that helped create major society guidelines for evaluation and management of ischemic heart disease. Consequently, risk benefit ratios of a guideline-based approach in these patients are not well defined, especially with regards to pharmacotherapies and percutaneous coronary interventions. In this article we offer a practical approach to defining the elderly population, and provide an evidenced based review of the diagnostic and therapeutic implications of advanced age in the evaluation and management of ischemic heart disease.